STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)								1 Months Ended		9 Months Ended
	Jun. 08, 2022	Mar. 16, 2022	Feb. 28, 2022	Mar. 30, 2021	Jan. 22, 2021	Jan. 14, 2021	Dec. 23, 2020	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2022	Sep. 30, 2021	Mar. 29, 2022	Mar. 17, 2022	Dec. 31, 2021	Jan. 31, 2021	Jan. 25, 2021	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Exercise price		$ 8.75				$ 30				$ 0.025						$ 8.75
Number of securities called by warrants or rights		655,738
Proceeds from warrants exercised											$ 6,671,000
Residual value of warrants and stock offering							$ 2,500,000	$ 2,000,000.0
Reclassification as a reduction in additional paid-in capital							300,000	200,000
Warrant liability, issuance costs							500,000	$ 500,000
Common stock, par value										$ 0.001				$ 0.001
Warrants issued								2,722,818							96,836		209,522
Proceeds from Issuance of Warrants											1,002,000
Preferred Stock, Shares Issued										0				0
Preferred stock per share									$ 1,000
Conversion price									7.625
Proceeds from Issuance of Common Stock										$ 7,823,000	$ 9,884,000
Deferred offering costs										$ 98,000				$ 694,000
Cantor Fitzerald and Co [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from Issuance of Common Stock				$ 50,000,000.0
Deferred offering costs			$ 700,000
Series A Convertible Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Preferred Stock, Shares Issued		3,000.000435
Series B Convertible Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Preferred Stock, Shares Issued		2,000.00029
Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Converted share													262,295
Series A Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Converted share												393,443
Series A and Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price									$ 9.525
Percentage of exercise of warrants									125.00%
Warrants issued									32,787
Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price					$ 15.60
Sales Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Payments to Acquire Investments			$ 400,000
Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants and rights outstanding term										5 years	5 years 10 months 13 days
Maximum [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Number of securities called by warrants or rights					427,522
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Estimated fair value, liability							5,200,000	$ 5,700,000
Warrant Description									The holder of the March 2022 Warrants may not exercise any portion of such warrants to the extent that the holder would own more than 4.99% of the outstanding common stock immediately after exercise, which percentage may be changed at the holder’s election to a lower percentage at any time or to a higher percentage not to exceed 9.99% upon 61 days’ notice to the Company
Exisitng Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from warrants exercised	$ 7,300,000					$ 9,200,000	$ 7,200,000
Noninterest expense	$ 700,000					$ 800,000
Pre-funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price						$ 34.375
Common Stock Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants						$ 8,100,000
Placement Agent Common Stock Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants					$ 400,000	500,000
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of securities called by warrants or rights		655,738
Fair Value Adjustment of Warrants						1,400,000
Common Stock [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Number of securities called by warrants or rights																320,641
Common stock, par value					$ 0.001
Sale of stock, price per share					$ 3.125
Common Stock [Member] | Maximum [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of shares					320,641
Additional Paid-in Capital [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants						100,000
Classified Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant liability, issuance costs						$ 700,000
Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from warrants exercised		$ 5,000,000.0
Warrants issued					19,238
Prefunded warrants sold								The holder of the pre-funded warrants sold in the registered direct offering has exercised 488,659, 545,000, and 1,689,159 of such warrants in June 2022, July 2022, and August 2022, respectively, leaving 3,168,318 June 2022 Warrants that remain outstanding and unexercised as of September 30, 2022
Warrants [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant exercisable description					Each January 25 Warrant is exercisable for one share of Common Stock at an exercise price of $30.00 per share. The January 25 Warrants are immediately exercisable and will expire five years from the date of issuance
Warrant Description					A holder may not exercise any portion of the January 25 Warrants to the extent that the holder would own more than 4.99% of the outstanding common stock immediately after exercise, which percentage may be changed at the holder’s election to a lower percentage at any time or to a higher percentage not to exceed 9.99% upon 61 days’ notice to the Company. The Company also issued to designees of the placement agent, warrants to purchase 6.0% of the aggregate number of common stock shares and pre-funded warrants sold in the offering (or warrants to purchase up to 19,238 shares of common stock)			The holder of the warrants may not exercise any portion of such warrants to the extent that the holder would own more than 4.99% of the outstanding common stock immediately after exercise, which percentage may be changed at the holder’s election to a lower percentage at any time or to a higher percentage not to exceed 9.99% upon 61 days’ notice to the Company. The Company also issued to designees of the placement agent, warrants to purchase 5.0% of the aggregate number of common stock shares and pre-funded warrants sold in the offering (or warrants to purchase up to 158,416 shares of common stock)
Warrants [Member] | Maximum [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued					427,522
Warrant One [Member]
Subsidiary, Sale of Stock [Line Items]
Remeasurement loss					$ 3,600,000
Warrant One [Member] | Maximum [Member] | Letter Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued							427,522
December 2020 [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from warrants exercised					6,700,000
Proceeds from Issuance of Warrants					1,000,000.0
January 25 Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Noninterest expense					100,000
Fair Value Adjustment of Warrants					$ 5,800,000
Series A and Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from warrants exercised									$ 4,500,000
Residual value of warrants and stock offering									1,900,000
Warrant liability, issuance costs									300,000
Noninterest expense									200,000
Series A and Series B Preferred Stock [Member] | Monte Carlo Simulation Model [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants									3,000,000.0
Series A and Series B Preferred Stock [Member] | Placement Agent Common Stock Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Fair Value Adjustment of Warrants									$ 100,000
Placement Agent [Member]
Subsidiary, Sale of Stock [Line Items]
Estimated fair value, liability								$ 300,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of shares	445,500					266,800	218,000
Exercise price	$ 0.001						$ 0.001
Number of securities called by warrants or rights						363,636
Warrants and rights outstanding term	5 years					5 years	5 years
Common stock, par value						$ 0.025
IPO [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Number of securities called by warrants or rights						363,636	427,522
IPO [Member] | Pre-Funded Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price	$ 0.001					$ 0.001	$ 0.025
Number of securities called by warrants or rights	1,138,659					96,836	209,522
Shares issued price per share	$ 2.524					$ 27.475	$ 18.6875
IPO [Member] | Common Stock and Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued price per share	$ 2.525						18.7125
IPO [Member] | Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price						30.00	15.60
Shares issued price per share						$ 27.50
IPO [Member] | Pre-funded Warrants One [Member]
Subsidiary, Sale of Stock [Line Items]
Number of securities called by warrants or rights	1,584,159
Shares issued price per share	$ 2.524
IPO [Member] | June 2022 Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price	$ 2.40
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Percentage of exercise of warrants	125.00%
Warrant, Exercise Price, Increase	$ 3.156						$ 23.39
Estimated fair value, liability							$ 300,000
Private Placement [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Number of securities called by warrants or rights	3,168,318					21,818	25,651
Percentage of exercise of warrants							125.00%
Percentage of warrant exercise price						125.00%